BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7774844)

  • 1. Participation in transvaginal ovarian cancer screening: compliance, correlation factors, and costs.
    Pavlik EJ; van Nagell JR; DePriest PD; Wheeler L; Tatman JM; Boone M; Sollars S; Rayens MK; Kryscio RK
    Gynecol Oncol; 1995 Jun; 57(3):395-400. PubMed ID: 7774844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing participation supports ultrasound screening for ovarian cancer.
    Pavlik EJ; Johnson TL; Depriest PD; Andrykowski MA; Kryscio RJ; Van Nagell JR
    Ultrasound Obstet Gynecol; 2000 May; 15(5):354-64. PubMed ID: 10976474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
    Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of self-reports of return for routine repeat screening in an ovarian cancer screening program.
    Lykins EL; Pavlik EL; Andrykowski MA
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):490-3. PubMed ID: 17372244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with return for routine annual screening in an ovarian cancer screening program.
    Andrykowski MA; Zhang M; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2007 Mar; 104(3):695-701. PubMed ID: 17145075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to decrease false-positive cases of ovarian cancer screening by transvaginal sonography.
    Misawa T; Asai M; Higashide K
    J Exp Clin Cancer Res; 1997 Jun; 16(2):217-20. PubMed ID: 9261750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography--study on size of ovary to select subjects requiring second screening].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1173-9. PubMed ID: 1453046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Is ultrasound screening for ovarian cancer possible in 1998?].
    Descamps P; Fondrinier E; Biquard F; Binelli C; Lepinard C; Loisel D; Crvencowitcz G; Platt LD; Karlan BY
    J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):476-81. PubMed ID: 9791573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mass-screening for ovarian cancer by transvaginal ultrasonography--study on ultrasonographic findings].
    Sato S; Sugo T; Maruyama H; Kunugi K; Saito Y; Hasuo Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1234-40. PubMed ID: 7844441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mass-screening for ovarian cancer by transvaginal ultrasonography--study on tumor markers at the second screening].
    Sato S; Sugo T; Maruyama H; Saito Y; Hasuo Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1247-53. PubMed ID: 7844443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer screening.
    Rosenthal A; Jacobs I
    Semin Oncol; 1998 Jun; 25(3):315-25. PubMed ID: 9633843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, demographic, and psychological characteristics of new, asymptomatic participants in a transvaginal ultrasound screening program for ovarian cancer.
    Salsman JM; Pavlik E; Boerner LM; Andrykowski MA
    Prev Med; 2004 Aug; 39(2):315-22. PubMed ID: 15226040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):683-8. PubMed ID: 1506730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaginal sonography: pilot study for using in ovarian screening procedures].
    Duda V; Rode G; Thein C; Schulz KD
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):388-93. PubMed ID: 2197167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for ovarian cancer].
    Ohmura M
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1958-63. PubMed ID: 1417004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
    Muto MG; Cramer DW; Brown DL; Welch WR; Harlow BL; Xu H; Brucks JP; Tsao SW; Berkowitz RS
    Gynecol Oncol; 1993 Oct; 51(1):12-20. PubMed ID: 8244166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer screening in asymptomatic postmenopausal women.
    DePriest PD; van Nagell JR; Gallion HH; Shenson D; Hunter JE; Andrews SJ; Powell DE; Pavlik EJ
    Gynecol Oncol; 1993 Nov; 51(2):205-9. PubMed ID: 8276295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a single center vascular screening and education program.
    Hupp JA; Martin JD; Hansen LO
    J Vasc Surg; 2007 Aug; 46(2):182-7; discussion 188-9. PubMed ID: 17664093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of ovarian cancer screening by women at increased risk.
    Schwartz M; Lerman C; Daly M; Audrain J; Masny A; Griffith K
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):269-73. PubMed ID: 7606202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.